DE1522361A1
(de)
|
1966-03-08 |
1969-07-24 |
Agfa Gevaert Ag |
Sensibilisierung lichtempfindlicher Polymerer
|
US3557142A
(en)
*
|
1968-02-20 |
1971-01-19 |
Sterling Drug Inc |
4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
|
DE1772867A1
(de)
|
1968-07-15 |
1971-06-16 |
Agfa Gevaert Ag |
Sensibilisierung von Schichten aus lichtvernetzbaren Polymeren
|
JPS5089367A
(es)
*
|
1973-12-14 |
1975-07-17 |
|
|
JPS57171986A
(en)
|
1981-04-14 |
1982-10-22 |
Taiho Yakuhin Kogyo Kk |
Heterocylic ring compound containing sulfur
|
DE3333450A1
(de)
*
|
1983-09-16 |
1985-04-11 |
Hoechst Ag, 6230 Frankfurt |
Trihalogenmethylgruppen enthaltende carbonylmethylenheterocyclen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt
|
US4978664A
(en)
*
|
1984-08-06 |
1990-12-18 |
Sterling Drug Inc. |
3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indole pharmaceutical compositions
|
US4885295A
(en)
*
|
1984-08-06 |
1989-12-05 |
Sterling Drug Inc. |
Method of use of 3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indoles
|
DE3533331A1
(de)
|
1985-09-18 |
1987-03-26 |
Heumann Ludwig & Co Gmbh |
Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
DE3807381A1
(de)
*
|
1988-03-07 |
1989-09-21 |
Hoechst Ag |
4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindung enthaelt
|
TW205041B
(es)
|
1989-08-07 |
1993-05-01 |
Fujisawa Pharmaceutical Co |
|
DE4021439A1
(de)
*
|
1989-12-14 |
1991-06-20 |
Bayer Ag |
2-iminopyridin-derivate
|
US6559186B1
(en)
*
|
1990-02-26 |
2003-05-06 |
Arc 1, Inc. |
Compositions and methods of treatment of sympathetically maintained pain
|
US4973587A
(en)
*
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
US5013837A
(en)
*
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
WO1992015564A1
(en)
|
1991-03-11 |
1992-09-17 |
Nippon Soda Co., Ltd. |
Novel heterocyclic compound
|
BR9306011A
(pt)
*
|
1992-03-03 |
1997-10-21 |
Idemitsu Kosan Co |
Derivados de pirazol
|
DE69319956T2
(de)
|
1992-04-30 |
1999-01-14 |
Hodogaya Chemical Co Ltd |
Benzothiazolederivate und diese enthaltende fungizide Zusammensetzungen für Landwirtschaft und Gartenbau
|
US5654322A
(en)
*
|
1992-08-11 |
1997-08-05 |
Wakunaga Seiyaku Kabushiki Kaisha |
Biphenylmethane derivatives and pharmaceuticals containing the same
|
US5530019A
(en)
*
|
1993-04-05 |
1996-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Indole derivatives useful as testosterone 5α-reductase inhibitors
|
US5395836A
(en)
|
1993-04-07 |
1995-03-07 |
Kyowa Hakko Kogyo Co., Ltd. |
8-tricycloalkyl xanthine derivatives
|
JPH06345736A
(ja)
|
1993-06-14 |
1994-12-20 |
Tokuyama Soda Co Ltd |
ウレタン化合物を製造する方法
|
MY115155A
(en)
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
AU2641295A
(en)
|
1994-05-17 |
1995-12-05 |
Dowelanco |
N-(5-isothiazolyl)amide pesticides
|
DE69529338T3
(de)
|
1994-07-08 |
2007-05-31 |
Ev3 Inc., Plymouth |
Intravaskuläre Filtereinrichtung
|
FR2735774B1
(fr)
|
1995-06-21 |
1997-09-12 |
Sanofi Sa |
Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
|
DE69631347T2
(de)
|
1995-09-15 |
2004-10-07 |
Upjohn Co |
Aminoaryl oxazolidinone n-oxide
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
US6323214B1
(en)
*
|
1997-10-29 |
2001-11-27 |
Medco Research, Inc |
Allosteric adenosine receptor modulators
|
US6358992B1
(en)
*
|
1998-11-25 |
2002-03-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with indole derivatives
|
WO2000063207A1
(en)
|
1999-04-20 |
2000-10-26 |
Syngenta Limited |
Pesticidal indazole or benzotriazole derivatives
|
DE19928033A1
(de)
|
1999-06-18 |
2000-12-21 |
Basf Ag |
Verwendung von cyclischen Enaminen als Lichtschutzmittel
|
FR2796643B1
(fr)
|
1999-07-22 |
2005-04-29 |
Sod Conseils Rech Applic |
Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
|
GB9918037D0
(en)
*
|
1999-07-30 |
1999-09-29 |
Biochemie Gmbh |
Organic compounds
|
CA2379421A1
(en)
|
1999-08-27 |
2001-03-08 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
|
AU6877300A
(en)
*
|
1999-09-14 |
2001-04-17 |
Shionogi & Co., Ltd. |
2-imino-1,3-thiazine derivatives
|
AU1095101A
(en)
|
1999-10-18 |
2001-04-30 |
University Of Connecticut, The |
Cannabimimetic indole derivatives
|
GB0002034D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
GB0006289D0
(en)
*
|
2000-03-15 |
2000-05-03 |
Smithkline Beecham Plc |
New use
|
GB0010437D0
(en)
|
2000-04-28 |
2000-06-14 |
Darwin Discovery Ltd |
Process
|
CN1944417A
(zh)
|
2000-06-30 |
2007-04-11 |
大日本住友制药株式会社 |
五元环化合物
|
US6369052B1
(en)
*
|
2000-08-07 |
2002-04-09 |
Georgetown University |
Combination of huperzine and nicotinic compounds as a neuroprotective agent
|
FR2816938B1
(fr)
*
|
2000-11-22 |
2003-01-03 |
Sanofi Synthelabo |
Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
|
US7173027B2
(en)
|
2001-01-29 |
2007-02-06 |
University Of Connecticut |
Receptor selective cannabimimetic aminoalkylindoles
|
WO2002102232A2
(en)
|
2001-06-14 |
2002-12-27 |
The Regents Of The University Of California |
A novel signaling pathway for the production of inflammatory pain and neuropathy
|
WO2003029199A1
(fr)
*
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Derives de benzene et procede de preparation et d'utilisation associe
|
WO2003037869A1
(en)
*
|
2001-11-01 |
2003-05-08 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
US6727247B2
(en)
|
2001-12-10 |
2004-04-27 |
Hoffman-La Roche Inc. |
Substituted benzothiazole amide derivatives
|
JP4522850B2
(ja)
|
2002-05-16 |
2010-08-11 |
メリアル リミテッド |
農薬ピリジンカルボキサミド誘導体
|
JP3902523B2
(ja)
*
|
2002-08-05 |
2007-04-11 |
富士フイルム株式会社 |
光情報記録媒体および情報記録方法
|
US20040077617A1
(en)
*
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Fused cycloalkyl amides and acids and their therapeutic applications
|
FR2847899B1
(fr)
|
2002-11-29 |
2006-04-28 |
Sanofi Synthelabo |
Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
|
US7390670B2
(en)
*
|
2003-02-20 |
2008-06-24 |
Lumigen, Inc. |
Signalling compounds and methods for detecting hydrogen peroxide
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
EP1640369A4
(en)
|
2003-06-27 |
2007-10-31 |
Dainippon Sumitomo Pharma Co |
THIAZOLIMINE COMPOUND AND OXAZOLIMINE COMPOUND
|
WO2005023818A2
(en)
|
2003-09-10 |
2005-03-17 |
Gpc Biotech Ag |
Heterobicyclic compounds as pharmaceutically active agents
|
ATE384058T1
(de)
|
2003-12-08 |
2008-02-15 |
Hoffmann La Roche |
Thiazolderivate
|
GB0402357D0
(en)
|
2004-02-03 |
2004-03-10 |
Glaxo Group Ltd |
Novel compounds
|
DE602004009344T2
(de)
|
2004-04-19 |
2008-07-10 |
Symed Labs Ltd., Hyderabad |
Neues verfahren zur herstellung von linezolid und verwandten verbindungen
|
SE0401342D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds
|
SE0401345D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds: Pyridine as scaffold
|
WO2006008754A1
(en)
|
2004-07-20 |
2006-01-26 |
Symed Labs Limited |
Novel intermediates for linezolid and related compounds
|
WO2006039164A2
(en)
*
|
2004-09-29 |
2006-04-13 |
Amr Technology, Inc. |
Novel cyclosporin analogues and their pharmaceutical uses
|
EP1820504A1
(en)
|
2004-11-15 |
2007-08-22 |
Taisho Pharmaceutical Co., Ltd |
Imine compound
|
WO2006069196A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Abbott Laboratories |
3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
|
FR2880023B1
(fr)
|
2004-12-23 |
2007-02-23 |
Sanofi Aventis Sa |
Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
|
US7759337B2
(en)
*
|
2005-03-03 |
2010-07-20 |
Amgen Inc. |
Phthalazine compounds and methods of use
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US7674912B2
(en)
*
|
2005-04-25 |
2010-03-09 |
H. Lundbeck A/S |
Pro-drugs of N-thiazol-2-yl-benzamide derivatives
|
US20070155738A1
(en)
*
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
TW200716636A
(en)
*
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
US7514068B2
(en)
*
|
2005-09-14 |
2009-04-07 |
Concert Pharmaceuticals Inc. |
Biphenyl-pyrazolecarboxamide compounds
|
US7872006B2
(en)
*
|
2005-10-21 |
2011-01-18 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity
|
AR057987A1
(es)
|
2005-11-24 |
2008-01-09 |
Astrazeneca Ab |
Compuestos agonistas de cb1 (receptor cannabinoide)
|
US8841334B2
(en)
*
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
BRPI0712720A2
(pt)
*
|
2006-05-31 |
2012-11-20 |
Abbott Lab |
compostos tiazàis como ligantes do receptor canabinàide e usos dos mesmos
|
EP2024349B1
(en)
*
|
2006-05-31 |
2017-08-02 |
AbbVie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
US20080089941A1
(en)
*
|
2006-06-01 |
2008-04-17 |
Mower Thomas E |
Fucoidan compositions and methods
|
WO2008002956A2
(en)
*
|
2006-06-27 |
2008-01-03 |
Abbott Laboratories |
Thiazoline and oxazoline derivatives and their methods of use
|
CN101547910A
(zh)
*
|
2006-07-28 |
2009-09-30 |
合成纤维有限公司 |
结晶埃罗替尼
|
WO2008028093A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Compounds as cb2 cannabinoid receptor ligands
|
WO2008028094A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Compounds as cb2 cannabinoid receptor ligands
|
WO2008063781A2
(en)
|
2006-10-12 |
2008-05-29 |
Abbott Laboratories |
Chemical compounds as cannabinoid receptor ligands
|
US8796267B2
(en)
*
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
US9763894B2
(en)
*
|
2006-12-05 |
2017-09-19 |
Virginia Commonwealth University |
Inflammation therapy
|
TW200831092A
(en)
*
|
2006-12-21 |
2008-08-01 |
Astrazeneca Ab |
Therapeutic agents
|
WO2008079687A1
(en)
|
2006-12-22 |
2008-07-03 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands and uses thereof
|
KR101335845B1
(ko)
*
|
2007-02-15 |
2013-12-02 |
에프. 호프만-라 로슈 아게 |
Taar1 리간드로서의 2-아미노옥사졸린
|
EP2142522A1
(en)
*
|
2007-03-28 |
2010-01-13 |
Abbott Laboratories |
1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
*
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8501794B2
(en)
*
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US7528131B2
(en)
*
|
2007-04-19 |
2009-05-05 |
Concert Pharmaceuticals Inc. |
Substituted morpholinyl compounds
|
JP2010527929A
(ja)
|
2007-05-18 |
2010-08-19 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての新規な化合物
|
US7531685B2
(en)
*
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
US8338623B2
(en)
|
2007-07-09 |
2012-12-25 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
WO2009035598A1
(en)
*
|
2007-09-10 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
US20090118238A1
(en)
*
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
US20090082471A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
US20090088416A1
(en)
*
|
2007-09-26 |
2009-04-02 |
Protia, Llc |
Deuterium-enriched lapaquistat
|
WO2009045476A1
(en)
*
|
2007-10-02 |
2009-04-09 |
Concert Pharmaceuticals, Inc. |
Pyrimidinedione derivatives
|
US9193713B2
(en)
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US8410124B2
(en)
*
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
US8044071B2
(en)
*
|
2007-10-18 |
2011-10-25 |
Abbott Laboratories |
Method for reducing side effects of CB2 receptor agonist therapy using a combination of a selective CB2 receptor agonist and a selective CB1 receptor antagonist
|
US20090105338A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
WO2009055006A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
JP2011504186A
(ja)
*
|
2007-11-21 |
2011-02-03 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての新規な化合物およびその使用
|
TW200942535A
(en)
*
|
2008-03-11 |
2009-10-16 |
Abbott Lab |
Novel compounds as cannabinoid receptor ligands
|
JP2012500198A
(ja)
*
|
2008-08-15 |
2012-01-05 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしてのイミン誘導体
|
US8846730B2
(en)
*
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
PE20110804A1
(es)
*
|
2008-09-16 |
2011-11-30 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de cannabinoides
|
WO2010054024A2
(en)
|
2008-11-04 |
2010-05-14 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands
|
PA8854001A1
(es)
*
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
WO2010111572A1
(en)
*
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2010111573A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8236822B2
(en)
*
|
2009-03-27 |
2012-08-07 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2011159785A1
(en)
*
|
2010-06-15 |
2011-12-22 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands
|